(SeaPRwire) – By: Christian Pierce
Philip Morris International’s second-quarter performance presented a paradox. On one hand, the company exceeded Wall Street’s expectations, with adjusted EPS landing at $2.20, besting the $2.03 consensus, and revenue surging to $11.2 billion, a 10.4% year-over-year jump. This marked the first time quarterly net revenues topped $11 billion. However, the stock took a hit after the Q3 guidance fell short. For Q3, Philip Morris projected adjusted EPS between $2.20 and $2.25, with the midpoint of $2.225 far below the analyst consensus of $2.43.
The smoke-free segment was the driving force behind growth. Revenue in this unit climbed 11.7%, and shipment volume rose 7.5%. Zyn nicotine pouches benefited from recent U.S. regulatory approval, contributing to the positive results. The international smoke-free segment saw a 14.2% revenue increase, driven by 8% volume growth, with IQOS heat-not-burn products leading the way. Yet, challenges emerged: IQOS faced pressure in Japan and Poland during the quarter.
Reported diluted EPS was $1.80, down 7.7% year-over-year due to a $511 million non-cash impairment charge related to the company’s RBH equity investment. Despite the Q3 guidance miss, Philip Morris maintained its full-year 2026 adjusted EPS forecast at $8.26–$8.41, representing 9.5% to 11.5% growth from 2025. Excluding currency effects, the growth estimate is 7.5% to 9.5%, with the company trimming its currency tailwind to $0.15 from $0.20 previously.
The key takeaway? While Philip Morris’ smoke-free segment continues to show promise, the Q3 guidance shortfall highlights the challenges ahead. Investors will be watching closely to see if the company can bridge the gap between its guidance and market expectations.
Author bio: Christian Pierce, a chief financial columnist with extensive experience dissecting trends in the consumer goods and tobacco industries, providing insights into corporate performance and market reactions.